IPP Bureau
BASF and Merck KGaA introduce a new standard for electronic exchange of quality and regulatory data
By IPP Bureau - June 07, 2023
The collaboration focuses on the development and sharing of Standard Quality and Regulatory Documentation (StaQRD), a standard guide for the electronic transfer of information
Mixed prospects for Merck lawsuit against US federal government, says GlobalData
By IPP Bureau - June 07, 2023
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
Piramal Critical Care appoints Jeffrey Hampton as President & COO
By IPP Bureau - June 07, 2023
Hampton joins PCC from Accord Healthcare, where he was the President and responsible for accelerating the firm's growth strategy
Unimed to expand operations into Singapore with Marine Pharma merger
By IPP Bureau - June 06, 2023
Establishes distribution center in top hub for international shipping
Agilent announces LC/TQ and LC/Q-TOF mass spectrometry solutions
By IPP Bureau - June 06, 2023
The superior Agilent 6495 Triple Quadrupole LC/MS (LC/TQ) System is ideal for demanding and challenging targeted analysis applications requiring the highest analytical sensitivity
USFDA approves Injectafer for the treatment of iron deficiency in adult patients with heart failure
By IPP Bureau - June 06, 2023
Injectafer is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
Dr. Reddy's completes Phase I study (IV route) of a proposed biosimilar of tocilizumabp
By IPP Bureau - June 06, 2023
The successful outcome of this study represents an important milestone in Dr. Reddy's commitment to make highquality biosimilar products more accessible and affordable
Keytruda+ chemotherapy improves overall survival versus chemotherapy alone for unresectable advanced pleural mesothelioma
By IPP Bureau - June 05, 2023
In Phase 3 CCTG IND.227/KEYNOTE-483 trial, KEYTRUDA plus chemotherapy also demonstrated statistically significant improvements in PFS and ORR compared to chemotherapy alone
Briefs: Ipca Laboratories, Lupin and Zydus
By IPP Bureau - June 05, 2023
The company has extended its full co-operation and support to the officials of the Income Tax Department
OMRON Healthcare to launch operations in March 2025 at Origins by Mahindra in Chennai
By IPP Bureau - June 05, 2023
The OMRON Healthcare factory will be built over 6.02 acres and will be manufacturing blood pressure monitors and supplying them mainly to the domestic market.
Evonik launches updated Biolys product for animal feeds
By IPP Bureau - June 05, 2023
The new Biolys provides higher concentration of L-lysine
DIC invests in US-based biotech startup
By IPP Bureau - June 05, 2023
Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes
International cooperation must to advance vaccine development for emerging pathogens: Health Minister Mandaviya
By IPP Bureau - June 04, 2023
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
Celanese showcases advanced medical materials solutions at Medtec China 2023
By IPP Bureau - June 04, 2023
elanese now offers Zytel Resin, Hytrel TPC, Crastin PBT and Micromax Electronic Inks and Paste following its 2022 acquisition of the majority of the Mobility & Materials (M&M) business from DuPont
Sun Pharma and Philogen enter into an agreement for commercializing NIDLEGY
By IPP Bureau - June 03, 2023
Sun Pharma will have exclusive rights to commercialise Nidlegy for indications of skin cancers in the territories of Europe, Australia and New Zealand. Philogen will complete pivotal clinical trials for the product in Europe
